Genmab — December 2017
-
check lige hvordan udlandet bevægede sig i lukkeauktionen
-
Hvis vi tager de bredere briller på, kunne det se ud til at europæisk biotek får bøllebank og US klarer sig overraskende og positivt godt - det kunne være trumps skattereform, der spøger. En så markant ændring af beskatningen gør det meget mere attraktivt at have amerikanske aktiver
-
aaaah - så det er ikke bare et tal, du har revet ud af røven
-
altid dejligt med lidt fakta til at berige debatten
-
det er det mest berømte tal i Genmabs historie. For alle andre er det bare en teknisk grænse
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
